• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Boehringer Ingelheim and Eko Health Partner to Bring AI-Powered Heart Disease Detection to Veterinary Medicine

by Jasmine Pennic 06/10/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
 Boehringer Ingelheim and Eko Health Partner to Bring AI-Powered Heart Disease Detection to Veterinary Medicine
Source Credit: Boehringer Ingelheim & Eko Health

What You Should Know: 

– Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early disease detection, have announced a strategic collaboration. The partnership aims to enhance the early detection and diagnosis of heart disease in dogs by combining Boehringer’s expertise in canine cardiology with Eko Health’s powerful AI algorithms and digital stethoscopes.

– The collaboration will leverage Eko Health’s technology, already trusted by healthcare professionals with over 650,000 devices sold for use in human medicine, and combine it with Boehringer’s proprietary algorithm. The result will be a canine-specific detection algorithm made available to veterinarians through a purpose-built Eko mobile app, set to launch in 2026.

Addressing a Common Canine Health Crisis

Heart murmurs in dogs are a common finding in myxomatous mitral valve disease (MMVD), a chronic heart condition that is a major cause of morbidity and mortality in dogs. MMVD affects approximately 10 to 15% of dogs in their lifetime, making early and accurate detection critical.

In a typical clinic visit, veterinarians rely on analog stethoscopes to detect murmurs, often in noisy environments and during time-constrained exams. This traditional method can miss subtle or early-stage murmurs, especially those that fall outside the range of human hearing.

This partnership aims to equip veterinarians with a simple, powerful tool to detect heart murmurs earlier and with greater confidence. The new tool will give veterinarians the ability to not only hear but also see and document the sounds of heart murmurs, which can then be shared with dog owners.

“As a longtime leader in canine cardiology, we know that early diagnosis of MMVD and consideration of early appropriate treatment are key to helping affected dogs live better and longer lives,” explained Dr. Erich Schött, Head of Pet Therapeutics and Pet Vaccines at Boehringer Ingelheim. “By collaborating with Eko Health, we look forward to simplifying and improving canine heart murmur detection so that more dogs and pet owners can have additional years of life to love.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Eko Devices, heart arrhythmia detection, heart disease

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |